Literature DB >> 23442940

Successful replacement of a HeartAssist 5 ventricular assist device with a HeartWare without removal of the original sewing/attachment rings: how to do it.

Diana García Sáez1, Prashant Mohite, Bartlomeij Zych, Anton Sabashnikov, André R Simon.   

Abstract

Despite technological advances in a newer generation of ventricular assist devices (VAD), complications, such as pump thromboses, remain a significant cause of morbidity and indeed mortality in these patients. We present the case of a 34-year old patient who underwent HeartAssist 5 (HA5) implantation as a bridge to cardiac transplant. After an initial uneventful recovery, he developed a pump thrombosis that was refractory to medical treatment. We present the surgical technique used to exchange the HA5 with a HeartWare (HVAD), leaving the old inflow-sewing ring in situ.

Entities:  

Keywords:  Circulatory assist devices

Mesh:

Year:  2013        PMID: 23442940      PMCID: PMC3653478          DOI: 10.1093/icvts/ivt066

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  HeartWare continuous-flow ventricular assist device thrombosis: the Bad Oeynhausen experience.

Authors:  Nadia Aissaoui; Jochen Börgermann; Jan Gummert; Michiel Morshuis
Journal:  J Thorac Cardiovasc Surg       Date:  2012-01-14       Impact factor: 5.209

2.  Current status of the MicroMed DeBakey Noon Ventricular Assist Device.

Authors:  George P Noon; Matthias Loebe
Journal:  Tex Heart Inst J       Date:  2010

3.  Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics.

Authors:  Abdallah Kamouh; Ranjit John; Peter Eckman
Journal:  Ann Thorac Surg       Date:  2012-07       Impact factor: 4.330

4.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

5.  Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator.

Authors:  Markus Rothenburger; Markus J Wilhelm; Dieter Hammel; Christoph Schmidt; Tonny D T Tjan; Dirk Böcker; Hans H Scheld; Christof Schmid
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.